1. Stress-impaired transcription factor expression and insulin secretion in transplanted human islets. Dai C, Kayton NS, Shostak A, Poffenberger G, Cyphert HA, Aramandla R, Thompson C, Papagiannis IG, Emfinger C, Shiota M, Stafford JM, Greiner DL, Herrera PL, Shultz LD, Stein R, Powers AC (2016) J Clin Invest 126(5): 1857-70
    › Primary publication · 27064285 (PubMed) · PMC4855919 (PubMed Central)
  2. CETP Expression Protects Female Mice from Obesity-Induced Decline in Exercise Capacity. Cappel DA, Lantier L, Palmisano BT, Wasserman DH, Stafford JM (2015) PLoS One 10(8): e0136915
    › Primary publication · 26313355 (PubMed) · PMC4551677 (PubMed Central)
  3. Pathway-selective insulin resistance and metabolic disease: the importance of nutrient flux. Otero YF, Stafford JM, McGuinness OP (2014) J Biol Chem 289(30): 20462-9
    › Primary publication · 24907277 (PubMed) · PMC4110258 (PubMed Central)
  4. Estrogen signaling prevents diet-induced hepatic insulin resistance in male mice with obesity. Zhu L, Martinez MN, Emfinger CH, Palmisano BT, Stafford JM (2014) Am J Physiol Endocrinol Metab 306(10): E1188-97
    › Primary publication · 24691030 (PubMed) · PMC4116406 (PubMed Central)
  5. Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance. Zhu L, Brown WC, Cai Q, Krust A, Chambon P, McGuinness OP, Stafford JM (2013) Diabetes 62(2): 424-34
    › Primary publication · 22966069 (PubMed) · PMC3554377 (PubMed Central)
  6. Cholesteryl ester transfer protein protects against insulin resistance in obese female mice. Cappel DA, Palmisano BT, Emfinger CH, Martinez MN, McGuinness OP, Stafford JM (2013) Mol Metab 2(4): 457-67
    › Primary publication · 24327961 (PubMed) · PMC3854988 (PubMed Central)
  7. Aldosterone deficiency prevents high-fat-feeding-induced hyperglycaemia and adipocyte dysfunction in mice. Luo P, Dematteo A, Wang Z, Zhu L, Wang A, Kim HS, Pozzi A, Stafford JM, Luther JM (2013) Diabetologia 56(4): 901-10
    › Primary publication · 23314847 (PubMed) · PMC3593801 (PubMed Central)
  8. Obesity and altered glucose metabolism impact HDL composition in CETP transgenic mice: a role for ovarian hormones. Martinez MN, Emfinger CH, Overton M, Hill S, Ramaswamy TS, Cappel DA, Wu K, Fazio S, McDonald WH, Hachey DL, Tabb DL, Stafford JM (2012) J Lipid Res 53(3): 379-89
    › Primary publication · 22215797 (PubMed) · PMC3276461 (PubMed Central)
  9. Central nervous system neuropeptide Y signaling via the Y1 receptor partially dissociates feeding behavior from lipoprotein metabolism in lean rats. Rojas JM, Stafford JM, Saadat S, Printz RL, Beck-Sickinger AG, Niswender KD (2012) Am J Physiol Endocrinol Metab 303(12): E1479-88
    › Primary publication · 23074243 (PubMed) · PMC3532466 (PubMed Central)
  10. Impaired-inactivation of FoxO1 contributes to glucose-mediated increases in serum very low-density lipoprotein. Wu K, Cappel D, Martinez M, Stafford JM (2010) Endocrinology 151(8): 3566-76
    › Primary publication · 20501667 (PubMed) · PMC2940519 (PubMed Central)